Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.
Identifieur interne : 000A25 ( Main/Exploration ); précédent : 000A24; suivant : 000A26Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.
Auteurs : Aye C. Paing [Royaume-Uni] ; Alison F. Kirk [Royaume-Uni] ; Andrew Collier [Royaume-Uni] ; Thomas Kubiak [Allemagne] ; Sebastien F M. Chastin [Belgique]Source :
- Diabetes research and clinical practice [ 1872-8227 ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Diabète de type 2.
- méthodes : Autosurveillance glycémique.
- thérapie : Diabète de type 2.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Mâle, Sujet âgé.
English descriptors
- KwdEn :
- MESH :
- methods : Blood Glucose Self-Monitoring.
- pathology : Diabetes Mellitus, Type 2.
- therapy : Diabetes Mellitus, Type 2.
- Adult, Aged, Female, Humans, Male, Middle Aged.
Abstract
AIMS
To assess continuous glucose monitoring (CGM) derived intra-day glucose profiles using global guideline for type 2 diabetes recommended by the International Diabetes Federation (IDF).
METHODS
The Cochrane Library, MEDLINE, PubMed, CINAHL and Science Direct were searched to identify observational studies reporting intra-day glucose profiles using CGM in people with type 2 diabetes on any anti-diabetes agents. Overall and subgroup analyses were conducted to summarise mean differences between reported glucose profiles (fasting glucose, pre-meal glucose, postprandial glucose and post-meal glucose spike/excursion) and the IDF targets.
RESULTS
Twelve observational studies totalling 731 people were included. Pooled fasting glucose (0.81 mmol/L, 95% CI, 0.53-1.09 mmol/L), postprandial glucose after breakfast (1.63 mmol/L, 95% CI, 0.79-2.48 mmol/L) and post-breakfast glucose spike (1.05 mmol/L, 95% CI, 0.13-1.96 mmol/L) were significantly higher than the IDF targets. Pre-lunch glucose, pre-dinner glucose and postprandial glucose after lunch and dinner were above the IDF targets but not significantly. Subgroup analysis showed significantly higher fasting glucose and postprandial glucose after breakfast in all groups: HbA1c <7% and ≥7% (53 mmol/mol) and duration of diabetes <10 years and ≥10 years.
CONCLUSIONS
Independent of HbA1c, fasting glucose and postprandial glucose after breakfast are not well-controlled in type 2 diabetes.
DOI: 10.1016/j.diabres.2018.10.010
PubMed: 30399393
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.</title><author><name sortKey="Paing, Aye C" sort="Paing, Aye C" uniqKey="Paing A" first="Aye C" last="Paing">Aye C. Paing</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Electronic address: AyeChan.Paing@gcu.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Kirk, Alison F" sort="Kirk, Alison F" uniqKey="Kirk A" first="Alison F" last="Kirk">Alison F. Kirk</name><affiliation wicri:level="1"><nlm:affiliation>Physical Activity for Health Group, School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Physical Activity for Health Group, School of Psychological Sciences and Health, University of Strathclyde, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Collier, Andrew" sort="Collier, Andrew" uniqKey="Collier A" first="Andrew" last="Collier">Andrew Collier</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Kubiak, Thomas" sort="Kubiak, Thomas" uniqKey="Kubiak T" first="Thomas" last="Kubiak">Thomas Kubiak</name><affiliation wicri:level="3"><nlm:affiliation>Health Psychology, Johannes Gutenberg University, Mainz, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Health Psychology, Johannes Gutenberg University, Mainz</wicri:regionArea><placeName><region type="land" nuts="2">Rhénanie-Palatinat</region><settlement type="city">Mayence</settlement></placeName></affiliation></author><author><name sortKey="Chastin, Sebastien F M" sort="Chastin, Sebastien F M" uniqKey="Chastin S" first="Sebastien F M" last="Chastin">Sebastien F M. Chastin</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Department of Movement and Sports Science, Ghent University, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Department of Movement and Sports Science, Ghent University, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30399393</idno><idno type="pmid">30399393</idno><idno type="doi">10.1016/j.diabres.2018.10.010</idno><idno type="wicri:Area/Main/Corpus">000667</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000667</idno><idno type="wicri:Area/Main/Curation">000667</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000667</idno><idno type="wicri:Area/Main/Exploration">000667</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.</title><author><name sortKey="Paing, Aye C" sort="Paing, Aye C" uniqKey="Paing A" first="Aye C" last="Paing">Aye C. Paing</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Electronic address: AyeChan.Paing@gcu.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Kirk, Alison F" sort="Kirk, Alison F" uniqKey="Kirk A" first="Alison F" last="Kirk">Alison F. Kirk</name><affiliation wicri:level="1"><nlm:affiliation>Physical Activity for Health Group, School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Physical Activity for Health Group, School of Psychological Sciences and Health, University of Strathclyde, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Collier, Andrew" sort="Collier, Andrew" uniqKey="Collier A" first="Andrew" last="Collier">Andrew Collier</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Kubiak, Thomas" sort="Kubiak, Thomas" uniqKey="Kubiak T" first="Thomas" last="Kubiak">Thomas Kubiak</name><affiliation wicri:level="3"><nlm:affiliation>Health Psychology, Johannes Gutenberg University, Mainz, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Health Psychology, Johannes Gutenberg University, Mainz</wicri:regionArea><placeName><region type="land" nuts="2">Rhénanie-Palatinat</region><settlement type="city">Mayence</settlement></placeName></affiliation></author><author><name sortKey="Chastin, Sebastien F M" sort="Chastin, Sebastien F M" uniqKey="Chastin S" first="Sebastien F M" last="Chastin">Sebastien F M. Chastin</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Department of Movement and Sports Science, Ghent University, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Department of Movement and Sports Science, Ghent University, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author></analytic><series><title level="j">Diabetes research and clinical practice</title><idno type="eISSN">1872-8227</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Blood Glucose Self-Monitoring (methods)</term><term>Diabetes Mellitus, Type 2 (pathology)</term><term>Diabetes Mellitus, Type 2 (therapy)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Autosurveillance glycémique (méthodes)</term><term>Diabète de type 2 (anatomopathologie)</term><term>Diabète de type 2 (thérapie)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Diabète de type 2</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Glucose Self-Monitoring</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Autosurveillance glycémique</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Diabète de type 2</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>AIMS</b></p><p>To assess continuous glucose monitoring (CGM) derived intra-day glucose profiles using global guideline for type 2 diabetes recommended by the International Diabetes Federation (IDF).</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The Cochrane Library, MEDLINE, PubMed, CINAHL and Science Direct were searched to identify observational studies reporting intra-day glucose profiles using CGM in people with type 2 diabetes on any anti-diabetes agents. Overall and subgroup analyses were conducted to summarise mean differences between reported glucose profiles (fasting glucose, pre-meal glucose, postprandial glucose and post-meal glucose spike/excursion) and the IDF targets.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Twelve observational studies totalling 731 people were included. Pooled fasting glucose (0.81 mmol/L, 95% CI, 0.53-1.09 mmol/L), postprandial glucose after breakfast (1.63 mmol/L, 95% CI, 0.79-2.48 mmol/L) and post-breakfast glucose spike (1.05 mmol/L, 95% CI, 0.13-1.96 mmol/L) were significantly higher than the IDF targets. Pre-lunch glucose, pre-dinner glucose and postprandial glucose after lunch and dinner were above the IDF targets but not significantly. Subgroup analysis showed significantly higher fasting glucose and postprandial glucose after breakfast in all groups: HbA1c <7% and ≥7% (53 mmol/mol) and duration of diabetes <10 years and ≥10 years.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Independent of HbA1c, fasting glucose and postprandial glucose after breakfast are not well-controlled in type 2 diabetes.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30399393</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8227</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Diabetes research and clinical practice</Title><ISOAbbreviation>Diabetes Res Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.</ArticleTitle><Pagination><MedlinePgn>289-299</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0168-8227(18)30721-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diabres.2018.10.010</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To assess continuous glucose monitoring (CGM) derived intra-day glucose profiles using global guideline for type 2 diabetes recommended by the International Diabetes Federation (IDF).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Cochrane Library, MEDLINE, PubMed, CINAHL and Science Direct were searched to identify observational studies reporting intra-day glucose profiles using CGM in people with type 2 diabetes on any anti-diabetes agents. Overall and subgroup analyses were conducted to summarise mean differences between reported glucose profiles (fasting glucose, pre-meal glucose, postprandial glucose and post-meal glucose spike/excursion) and the IDF targets.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve observational studies totalling 731 people were included. Pooled fasting glucose (0.81 mmol/L, 95% CI, 0.53-1.09 mmol/L), postprandial glucose after breakfast (1.63 mmol/L, 95% CI, 0.79-2.48 mmol/L) and post-breakfast glucose spike (1.05 mmol/L, 95% CI, 0.13-1.96 mmol/L) were significantly higher than the IDF targets. Pre-lunch glucose, pre-dinner glucose and postprandial glucose after lunch and dinner were above the IDF targets but not significantly. Subgroup analysis showed significantly higher fasting glucose and postprandial glucose after breakfast in all groups: HbA1c <7% and ≥7% (53 mmol/mol) and duration of diabetes <10 years and ≥10 years.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Independent of HbA1c, fasting glucose and postprandial glucose after breakfast are not well-controlled in type 2 diabetes.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paing</LastName><ForeName>Aye C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Electronic address: AyeChan.Paing@gcu.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirk</LastName><ForeName>Alison F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Physical Activity for Health Group, School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collier</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubiak</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Health Psychology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chastin</LastName><ForeName>Sebastien F M</ForeName><Initials>SFM</Initials><AffiliationInfo><Affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Department of Movement and Sports Science, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Diabetes Res Clin Pract</MedlineTA><NlmUniqueID>8508335</NlmUniqueID><ISSNLinking>0168-8227</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">Glucose</Keyword><Keyword MajorTopicYN="N">Glucose profiles</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30399393</ArticleId><ArticleId IdType="pii">S0168-8227(18)30721-6</ArticleId><ArticleId IdType="doi">10.1016/j.diabres.2018.10.010</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Belgique</li><li>Royaume-Uni</li></country><region><li>Rhénanie-Palatinat</li></region><settlement><li>Mayence</li></settlement></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Paing, Aye C" sort="Paing, Aye C" uniqKey="Paing A" first="Aye C" last="Paing">Aye C. Paing</name></noRegion><name sortKey="Collier, Andrew" sort="Collier, Andrew" uniqKey="Collier A" first="Andrew" last="Collier">Andrew Collier</name><name sortKey="Kirk, Alison F" sort="Kirk, Alison F" uniqKey="Kirk A" first="Alison F" last="Kirk">Alison F. Kirk</name></country><country name="Allemagne"><region name="Rhénanie-Palatinat"><name sortKey="Kubiak, Thomas" sort="Kubiak, Thomas" uniqKey="Kubiak T" first="Thomas" last="Kubiak">Thomas Kubiak</name></region></country><country name="Belgique"><noRegion><name sortKey="Chastin, Sebastien F M" sort="Chastin, Sebastien F M" uniqKey="Chastin S" first="Sebastien F M" last="Chastin">Sebastien F M. Chastin</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30399393
|texte= Are glucose profiles well-controlled within the targets recommended by the International diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30399393" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |